speb/financial-data huggingface dataset:
Financial ratios for NTG.DE — quarterly report dated 2025-09-30
Total revenue: 57703529.4117647
Gross profit: 31214117.647058826
Operating income: 6047058.823529412
Net income: 3987058.823529412
Capital expenditures: 7971764.705882353
Operating cash flow: -10005882.352941176
Depreciation & amortization: 3417647.0588235296
Net tangible assets: 182568235.29411766
Owner earnings: -567058.8235294111
Return on net tangible assets (%): -0.3106010323295718
Capex to operating income (%): 131.82879377431905
Buffett classification: The Gruesome
Stock price: 15.988235294117647
P/E ratio: 13.20762173199574
Shares outstanding: 8800000
Book value: 184432941.17647058
P/B ratio: 0.7628597672994489
Market cap (USD): 140696470.5882353
Debt to equity: 0.5801821800367423
Current ratio: 6.830077696325885
Quick ratio: 4.635046749484219
Effective tax rate (%): 26.945462384134512
Interest coverage ratio: 5.4855923159018145
COGS to revenue (%): 45.906051215136195
Free cash flow (dilution-adjusted): -18036470.588235296
Buyback yield (%): 0
Retained earnings: 126727058.82352942
Inventory turnover: 0.4502749725027497
Receivables turnover: 12.547454591967254
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8267566539788824
FCF margin (%): -31.257135866905895
Revenue growth (%): -6.986270196465154
Rule of 40 score: -38.24340606337105
Financial ratios for NTG.DE — quarterly report dated 2025-12-31
Total revenue: 49695294.11764706
Gross profit: 24288235.29411765
Operating income: 3921176.470588235
Net income: 482352.9411764706
Capital expenditures: 8202352.94117647
Operating cash flow: 4530588.235294118
Depreciation & amortization: 3505882.3529411764
Net tangible assets: 184348235.29411766
Owner earnings: -4214117.647058823
Return on net tangible assets (%): -2.2859549701332513
Capex to operating income (%): 209.18091809180916
Buffett classification: The Gruesome
Stock price: 14.082352941176472
P/E ratio: 11.129269981705617
Shares outstanding: 8800000
Book value: 186216470.5882353
P/B ratio: 0.6654873518485761
Market cap (USD): 123924705.88235295
Debt to equity: 0.5735260670693184
Current ratio: 7.844916957579605
Quick ratio: 5.150904474769915
Effective tax rate (%): 36.6306027820711
Interest coverage ratio: 3.9304245283018866
COGS to revenue (%): 51.12568357756682
Free cash flow (dilution-adjusted): -3729411.7647058824
Buyback yield (%): 0
Retained earnings: 127209411.76470588
Inventory turnover: 0.4240080105236291
Receivables turnover: 12.981253841425938
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1827411347643566
FCF margin (%): -7.504557183778793
Revenue growth (%): -13.878241722394385
Rule of 40 score: -21.38279890617318
Financial ratios for NTG.DE — annual report dated 2025-12-31
Total revenue: 234771764.70588237
Gross profit: 120869411.76470588
Operating income: 20394117.647058822
Net income: 11382352.94117647
Capital expenditures: 28936470.588235296
Operating cash flow: 18628235.29411765
Depreciation & amortization: 13647058.823529413
Net tangible assets: 184348235.29411766
Owner earnings: -3907058.823529415
Return on net tangible assets (%): -2.119390412007966
Capex to operating income (%): 141.88635708104994
Buffett classification: The Gruesome
Stock price: 14.082352941176472
P/E ratio: 10.887441860465117
Shares outstanding: 8800000
Book value: 186216470.5882353
P/B ratio: 0.6654873518485761
Market cap (USD): 123924705.88235295
Debt to equity: 0.5735260670693184
Current ratio: 7.844916957579605
Quick ratio: 5.150904474769915
Effective tax rate (%): 26.74894003634161
Interest coverage ratio: 4.588406564319745
COGS to revenue (%): 48.516205977269536
SG&A to revenue (%): 9.274088476417647
Free cash flow (dilution-adjusted): -10624705.88235294
Buyback yield (%): 0
Retained earnings: 127209411.76470588
Inventory turnover: 1.9008697700901185
Receivables turnover: 61.32636754763368
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.151460417383775
FCF margin (%): -4.525546713704423
Revenue growth (%): 8.710553688295047
Rule of 40 score: 4.185006974590624
Financial ratios for ONCO3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.9736842105263157
Shares outstanding: 1122545684
Market cap (USD): 2215550692.105263
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ONCO3.SA — annual report dated 2022-12-31
Total revenue: 774290151.5151515
Gross profit: 275020265.1515151
Operating income: 84446401.51515152
Net income: 21547348.484848484
Capital expenditures: 56852083.33333333
Operating cash flow: -51447727.27272727
Depreciation & amortization: 33172727.27272727
Net tangible assets: -340280113.6363636
Owner earnings: -2132007.575757578
Capex to operating income (%): 67.32327525304062
Buffett classification: The Good
Stock price: 1.1442125237191652
P/E ratio: 59.60969308974947
Shares outstanding: 1122545684
Book value: 498571212.1212121
P/B ratio: 2.576223413732574
Market cap (USD): 1284430830.0796964
Debt to equity: 1.319745515214689
Current ratio: 1.5010144540453114
Quick ratio: 1.4139657480383947
Effective tax rate (%): 6.392957051176566
Interest coverage ratio: 1.124608737543288
COGS to revenue (%): 64.48098111368869
SG&A to revenue (%): 23.991109158633076
Free cash flow (dilution-adjusted): -110398674.24242423
Buyback yield (%): 1.1503886876321825
Retained earnings: -54638636.36363636
Inventory turnover: 16.080232040356965
Receivables turnover: 5.853832176623629
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.036644835476998
FCF margin (%): -14.258049650559702
Rule of 40 score: -14.258049650559702
Financial ratios for ONCO3.SA — annual report dated 2023-12-31
Total revenue: 1131706391.7525773
Gross profit: 397644536.08247423
Operating income: 152552577.31958765
Net income: 64445773.19587629
Capital expenditures: 64267010.309278354
Operating cash flow: -10631546.391752578
Depreciation & amortization: 53064948.45360825
Net tangible assets: -389562474.22680414
Owner earnings: 53243711.34020619
Return on net tangible assets (%): -13.667566786529747
Capex to operating income (%): 42.127777477428765
Buffett classification: The Good
Stock price: 2.691511387163561
P/E ratio: 46.88196511995042
Shares outstanding: 1122545684
Book value: 552447628.8659794
P/B ratio: 5.469015221043276
Market cap (USD): 3021344491.097308
Debt to equity: 1.7002031446932881
Current ratio: 1.7096139850191967
Quick ratio: 1.595992860831354
Effective tax rate (%): -3.320133016878334
Interest coverage ratio: 1.3217146491171659
COGS to revenue (%): 64.86327734999571
SG&A to revenue (%): 21.353922987565902
Free cash flow (dilution-adjusted): -84556907.21649486
Buyback yield (%): 0.23035419611834115
Retained earnings: -13376082.474226804
Inventory turnover: 17.250033916700584
Receivables turnover: 6.058545889645854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.04630741038055
FCF margin (%): -7.471629376021176
Revenue growth (%): 46.16050450054469
Rule of 40 score: 38.68887512452351
Financial ratios for ONCO3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.8305709023941068
Shares outstanding: 1122545684
Market cap (USD): 932353781.7384899
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ONCO3.SA — annual report dated 2024-12-31
Total revenue: 1007641909.3851134
Gross profit: 333400970.87378645
Operating income: -23102427.18446602
Net income: -104561488.67313917
Capital expenditures: 34667475.728155345
Operating cash flow: -29911165.04854369
Depreciation & amortization: 52812135.9223301
Net tangible assets: -97761650.4854369
Owner earnings: -86416828.47896442
Buffett classification: The Gruesome
Stock price: 0.37802907915993533
Shares outstanding: 1122545684
Book value: 547317961.1650486
P/B ratio: 0.7753352554595074
Market cap (USD): 424354911.23747975
Debt to equity: 1.6196660679837689
Current ratio: 1.899874694583333
Quick ratio: 1.8080621847492626
Interest coverage ratio: -0.23727796686787034
COGS to revenue (%): 66.9127526586071
SG&A to revenue (%): 22.42995156592172
Free cash flow (dilution-adjusted): -69052103.55987056
Buyback yield (%): 0
Retained earnings: -115058899.6763754
Inventory turnover: 18.499829067418474
Receivables turnover: 3.0391334563843877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6318544275165312
FCF margin (%): -6.852841561741687
Revenue growth (%): -10.962603310504932
Rule of 40 score: -17.81544487224662
Financial ratios for ONCO3.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.37802907915993533
Shares outstanding: 1122545684
Market cap (USD): 424354911.23747975
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ONCO3.SA — quarterly report dated 2025-03-31
Total revenue: 259228472.22222224
Gross profit: 71570138.8888889
Operating income: 5406423.611111111
Net income: -22912152.77777778
Capital expenditures: 6848611.111111111
Operating cash flow: -13344618.055555556
Depreciation & amortization: 12866145.833333334
Net tangible assets: -128406423.61111112
Owner earnings: -16894618.055555556
Capex to operating income (%): 126.67544394849234
Buffett classification: The Gruesome
Stock price: 1.0538194444444446
Shares outstanding: 1122545684
Book value: 562994965.2777777
P/B ratio: 2.1011919147318214
Market cap (USD): 1182960469.076389
Debt to equity: 1.6831945100160324
Current ratio: 1.8055536342214193
Quick ratio: 1.7238717770813239
Interest coverage ratio: 0.197567598431691
COGS to revenue (%): 72.39109644270258
SG&A to revenue (%): 24.03258601244612
Free cash flow (dilution-adjusted): -20888888.88888889
Buyback yield (%): 0.054183739776416134
Retained earnings: -148881597.22222224
Inventory turnover: 5.685180509972229
Receivables turnover: 0.7511430720202028
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.366444590803148
FCF margin (%): -8.058099756488941
Rule of 40 score: -8.058099756488941
Financial ratios for ONCO3.SA — quarterly report dated 2025-06-30
Total revenue: 267224270.07299268
Gross profit: 80293248.17518248
Operating income: 9129562.04379562
Net income: -25728467.15328467
Capital expenditures: 7104744.525547445
Operating cash flow: -82030839.41605839
Depreciation & amortization: 17949817.518248174
Net tangible assets: -161336861.3138686
Owner earnings: -14883394.16058394
Capex to operating income (%): 77.8213072156706
Buffett classification: The Gruesome
Stock price: 0.9361313868613138
Shares outstanding: 1122545684
Book value: 565443430.6569343
P/B ratio: 1.8584533677528454
Market cap (USD): 1050850247.9781021
Debt to equity: 1.7148068662602505
Current ratio: 1.4015964694231575
Quick ratio: 1.3090721103039409
Interest coverage ratio: 0.3066334066769225
COGS to revenue (%): 69.95286088600774
SG&A to revenue (%): 24.05924928417244
Free cash flow (dilution-adjusted): -90140145.98540145
Buyback yield (%): 0
Retained earnings: -182217153.28467152
Inventory turnover: 4.599106561609087
Receivables turnover: 0.8266808098416626
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6337699965961623
FCF margin (%): -33.73202065844526
Revenue growth (%): 3.08445973631943
Rule of 40 score: -30.647560922125827
Financial ratios for ONCO3.SA — quarterly report dated 2025-09-30
Total revenue: 265600187.9699248
Gross profit: 85176503.75939849
Operating income: -312523684.2105263
Net income: -353514473.6842105
Capital expenditures: 9960714.285714285
Operating cash flow: 28525187.96992481
Depreciation & amortization: 13751691.729323307
Net tangible assets: -436865977.443609
Owner earnings: -349723496.2406014
Buffett classification: The Gruesome
Stock price: 0.6015037593984962
Shares outstanding: 1122545684
Book value: 225281203.00751877
P/B ratio: 2.997211662617147
Market cap (USD): 675215449.0225563
Debt to equity: 4.0562037753985
Current ratio: 1.1222091854635627
Quick ratio: 1.0595624990624877
Interest coverage ratio: -9.66345254078685
COGS to revenue (%): 67.93055591924376
SG&A to revenue (%): 20.069667719514534
Free cash flow (dilution-adjusted): 17812593.984962404
Buyback yield (%): 0
Retained earnings: -541517105.2631578
Inventory turnover: 5.6055760605494305
Receivables turnover: 1.4226298949081075
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.295332048119008
FCF margin (%): 6.706544193778736
Revenue growth (%): -0.6077599548215642
Rule of 40 score: 6.0987842389571725
Financial ratios for ONCO3.SA — annual report dated 2025-12-31
Total revenue: 1047329744.5255474
Gross profit: 325967335.76642334
Operating income: -450094708.02919704
Net income: -661275182.4817518
Capital expenditures: 30678467.15328467
Operating cash flow: -21647262.773722626
Depreciation & amortization: 54268978.10218978
Net tangible assets: -325084306.56934303
Owner earnings: -637684671.5328467
Buffett classification: The Gruesome
Stock price: 0.48653500897666063
Shares outstanding: 1122545684
Book value: 193869890.5109489
P/B ratio: 2.8171356212263765
Market cap (USD): 546157774.4416517
Debt to equity: 3.5756692115168667
Current ratio: 0.5567595935362576
Quick ratio: 0.5211042418789913
Interest coverage ratio: -3.876504461914207
COGS to revenue (%): 68.87634124111595
SG&A to revenue (%): 23.71920108959751
Free cash flow (dilution-adjusted): -56373540.145985395
Buyback yield (%): 0.12335677697273223
Retained earnings: -791031386.8613138
Inventory turnover: 21.312971419636934
Receivables turnover: 2.822324888373099
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -127.89340725323477
FCF margin (%): -5.382597070373788
Revenue growth (%): 3.9386844444225697
Rule of 40 score: -1.4439126259512185
Financial ratios for ONCO3.SA — quarterly report dated 2025-12-31
Total revenue: 249786313.86861312
Gross profit: 87757481.75182481
Operating income: -161508029.19708028
Net income: -265324999.99999997
Capital expenditures: 6705291.970802919
Operating cash flow: 46717700.729927
Depreciation & amortization: 29979744.52554744
Net tangible assets: -325084306.56934303
Owner earnings: -242050547.44525546
Buffett classification: The Gruesome
Stock price: 0.48653500897666063
Shares outstanding: 1122545684
Book value: 193869890.5109489
P/B ratio: 2.8171356212263765
Market cap (USD): 546157774.4416517
Debt to equity: 3.5756692115168667
Current ratio: 0.5567595935362576
Quick ratio: 0.5211042418789913
Interest coverage ratio: -6.1702732849972115
COGS to revenue (%): 64.86697754065702
SG&A to revenue (%): 26.780846986730992
Free cash flow (dilution-adjusted): 38430291.97080292
Buyback yield (%): 0
Retained earnings: -791031386.8613138
Inventory turnover: 4.787213508952592
Receivables turnover: 0.6731195538857964
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -45.89214621787912
FCF margin (%): 15.385267261286836
Revenue growth (%): -5.954014649681786
Rule of 40 score: 9.43125261160505
Financial ratios for PRECOT.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.030594751417644
Shares outstanding: 12000000
Market cap (USD): 48367137.01701173
Buyback yield (%): 0
Retained earnings: 35288474.21864697
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRECOT.NS — annual report dated 2023-03-31
Total revenue: 111899257.0036541
Gross profit: 30703775.88306943
Operating income: 218599.26918392206
Net income: -3169634.5919610234
Capital expenditures: 3396747.8684531064
Operating cash flow: 5996674.786845311
Depreciation & amortization: 4067892.8136419
Net tangible assets: 49367941.53471377
Owner earnings: -2498489.6467722296
Return on net tangible assets (%): -5.060955691286787
Capex to operating income (%): 1553.8697275310637
Buffett classification: The Gruesome
Stock price: 2.192204628501827
Shares outstanding: 12000000
Book value: 49416991.47381243
P/B ratio: 0.5323362422004689
Market cap (USD): 26306455.542021923
Debt to equity: 0.9334885331644127
Current ratio: 1.2293595401981139
Quick ratio: 0.5022545434879928
Interest coverage ratio: 0.052903393162972635
COGS to revenue (%): 72.561233465503
SG&A to revenue (%): 4.168052240307942
Free cash flow (dilution-adjusted): 2110535.9317904995
Buyback yield (%): 0
Retained earnings: 28546857.490864802
Inventory turnover: 2.75450572272342
Receivables turnover: 7.739000669702088
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.31280141580679827
FCF margin (%): 1.8861036152559791
Rule of 40 score: 1.8861036152559791
Financial ratios for PRECOT.NS — annual report dated 2024-03-31
Total revenue: 96152776.11224367
Gross profit: 28753591.557740737
Operating income: 6366998.441060079
Net income: 2012519.4867490106
Capital expenditures: 7199448.375104928
Operating cash flow: 14517975.776471999
Depreciation & amortization: 2718983.0914977817
Net tangible assets: 50116236.95886797
Owner earnings: -2467945.7968581356
Return on net tangible assets (%): -4.924443546876154
Capex to operating income (%): 113.07444852941175
Buffett classification: The Gruesome
Stock price: 3.8163387715930903
P/E ratio: 22.75558848530469
Shares outstanding: 12000000
Book value: 50151528.960306995
P/B ratio: 0.9131539199006855
Market cap (USD): 45796065.25911708
Debt to equity: 0.8924485000009563
Current ratio: 1.132010726419465
Quick ratio: 0.5092738164690541
Effective tax rate (%): 10.905664682578713
Interest coverage ratio: 1.757545664594464
COGS to revenue (%): 70.09593199454241
SG&A to revenue (%): 3.9325881933306563
Free cash flow (dilution-adjusted): 5576220.170284207
Buyback yield (%): 0
Retained earnings: 30117771.915097732
Inventory turnover: 2.419758050801668
Receivables turnover: 6.127722468855774
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.136493126687999
FCF margin (%): 5.799333514588099
Revenue growth (%): -14.07201559068102
Rule of 40 score: -8.27268207609292
Financial ratios for PRECOT.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 51987709.03010034
Buffett classification: The Gruesome
Stock price: 5.172718585762064
Shares outstanding: 12000000
Book value: 52020066.889632106
P/B ratio: 1.1932438141773363
Market cap (USD): 62072623.02914477
Debt to equity: 0.806990622531641
Current ratio: 1.0903293545571155
Quick ratio: 0.5776353068557266
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRECOT.NS — quarterly report dated 2024-12-31
Total revenue: 23765497.1441893
Gross profit: 10645110.15269845
Operating income: 2521401.095698799
Net income: 1076255.9738897306
Capital expenditures: 0
Depreciation & amortization: 517624.4317519524
Owner earnings: 1593880.405641683
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.522788203753351
P/E ratio: 18.181887103062863
Shares outstanding: 12000000
Market cap (USD): 78273458.44504021
Effective tax rate (%): 26.173101822648647
Interest coverage ratio: 2.6904687869252104
COGS to revenue (%): 55.20771104381801
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRECOT.NS — quarterly report dated 2025-03-31
Total revenue: 25523801.730184708
Gross profit: 10995429.03904606
Operating income: 2662485.3869534717
Net income: 437502.92260930553
Capital expenditures: 0
Depreciation & amortization: 625216.2730886135
Net tangible assets: 52248199.67266776
Owner earnings: 1062719.195697919
Return on net tangible assets (%): 2.0339824192140576
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.111798342863811
P/E ratio: 35.05209733715561
Shares outstanding: 12000000
Book value: 52431342.06219312
P/B ratio: 1.1699410639079857
Market cap (USD): 61341580.114365734
Debt to equity: 0.7346530428138206
Current ratio: 1.049568969597313
Quick ratio: 0.47989863517181036
Effective tax rate (%): 19.53385581861712
Interest coverage ratio: 5.654005610585635
COGS to revenue (%): 56.92088053621435
Buyback yield (%): 0
Retained earnings: 32995031.564180497
Inventory turnover: 0.5899977022146093
Receivables turnover: 1.9285826594987272
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.003050592805621
Revenue growth (%): 7.398560086193349
Rule of 40 score: 7.398560086193349
Financial ratios for PRECOT.NS — annual report dated 2025-03-31
Total revenue: 97151052.13935001
Gross profit: 41208767.82791676
Operating income: 10787596.446107084
Net income: 3844680.8510638294
Capital expenditures: 5145031.5641805
Operating cash flow: 13539852.700490998
Depreciation & amortization: 2537795.183539864
Net tangible assets: 52248199.67266776
Owner earnings: 1237444.4704231936
Return on net tangible assets (%): 2.3683963814556646
Capex to operating income (%): 47.69395657210727
Buffett classification: The Good
Stock price: 5.111798342863811
P/E ratio: 15.954921225097896
Shares outstanding: 12000000
Book value: 52431342.06219312
P/B ratio: 1.1699410639079857
Market cap (USD): 61341580.114365734
Debt to equity: 0.7346530428138206
Current ratio: 1.049568969597313
Quick ratio: 0.47989863517181036
Effective tax rate (%): 23.764627234670396
Interest coverage ratio: 3.216787921676352
COGS to revenue (%): 57.5827879158649
SG&A to revenue (%): 4.1789340723037585
Free cash flow (dilution-adjusted): 8315641.805003506
Buyback yield (%): 0
Retained earnings: 32995031.564180497
Inventory turnover: 2.2718180419830074
Receivables turnover: 7.340749488992809
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.219166707971652
FCF margin (%): 8.559497423739524
Revenue growth (%): 1.0382186219366252
Rule of 40 score: 9.59771604567615
Financial ratios for PRECOT.NS — quarterly report dated 2025-09-30
Total revenue: 23084250.28184893
Gross profit: 10895783.540022548
Operating income: 2057406.9898534385
Net income: 792322.4351747463
Capital expenditures: 0
Depreciation & amortization: 786302.1420518602
Net tangible assets: 51993066.51634724
Owner earnings: 1578624.5772266067
Return on net tangible assets (%): 3.036221332954594
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.5304396843292
P/E ratio: 23.574743642060277
Shares outstanding: 12000000
Book value: 52168759.86471251
P/B ratio: 1.0421040552417586
Market cap (USD): 54365276.2119504
Debt to equity: 0.8129665042921799
Current ratio: 1.023368329475643
Quick ratio: 0.47738572799943463
Effective tax rate (%): 18.60203845262914
Interest coverage ratio: 1.8358432674412757
COGS to revenue (%): 52.79992459365307
Buyback yield (%): 0
Inventory turnover: 0.546534582391156
Receivables turnover: 1.9105128109429528
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.172750356189438
Revenue growth (%): -9.55794702577845
Rule of 40 score: -9.55794702577845
Financial ratios for PRECOT.NS — quarterly report dated 2025-12-31
Total revenue: 22334788.904979393
Gross profit: 10049682.522000669
Operating income: 1663172.5520775316
Net income: 643522.3348557425
Capital expenditures: 0
Depreciation & amortization: 840258.4382310349
Owner earnings: 1483780.7730867774
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.343878801381308
P/E ratio: 17.6723897546233
Shares outstanding: 12000000
Market cap (USD): 52126545.616575696
Effective tax rate (%): 27.500564744860824
Interest coverage ratio: 1.8805562203216908
COGS to revenue (%): 55.00435412774303
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.2466351201313906
Rule of 40 score: -3.2466351201313906
Financial ratios for PZZA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 115.34
Shares outstanding: 32902014
Market cap (USD): 3794918294.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PZZA — annual report dated 2022-12-31
Total revenue: 2102103000
Gross profit: 388430000
Operating income: 121095000
Net income: 69349000
Capital expenditures: 78391000
Operating cash flow: 117808000
Depreciation & amortization: 52032000
Net tangible assets: -357009000
Owner earnings: 42990000
Return on net tangible assets (%): -12.041713234120149
Capex to operating income (%): 64.73512531483546
Buffett classification: The Good
Stock price: 72.37
P/E ratio: 34.33530048277553
Shares outstanding: 32902014
Book value: -269447000
Market cap (USD): 2381118753.1800003
Debt to equity: -2.996002924508345
Current ratio: 0.9467560728172366
Quick ratio: 0.790690044011661
Effective tax rate (%): 17.214005180914178
Interest coverage ratio: 4.793753216420569
COGS to revenue (%): 81.52183789281496
SG&A to revenue (%): 10.242266910803135
Free cash flow (dilution-adjusted): 21029000
Buyback yield (%): 5.249633174870495
Retained earnings: 195856000
Inventory turnover: 41.41107244695761
Receivables turnover: 17.79015918958032
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.213831438730033
FCF margin (%): 1.0003791441237655
Rule of 40 score: 1.0003791441237655
Financial ratios for PZZA — annual report dated 2023-12-31
Total revenue: 2135713000
Gross profit: 419315000
Operating income: 147142000
Net income: 82799000
Capital expenditures: 76620000
Operating cash flow: 193055000
Depreciation & amortization: 64090000
Net tangible assets: -535298000
Owner earnings: 70269000
Return on net tangible assets (%): -13.127080616777945
Capex to operating income (%): 52.07214799309511
Buffett classification: The Good
Stock price: 68.55
P/E ratio: 27.239858690322347
Shares outstanding: 32902014
Book value: -442765000
Market cap (USD): 2255433059.7
Debt to equity: -2.181114135037774
Current ratio: 0.7584406886498838
Quick ratio: 0.639837686640665
Effective tax rate (%): 20.134461238702457
Interest coverage ratio: 3.384987002231475
COGS to revenue (%): 80.36650991963808
SG&A to revenue (%): 9.743022587772796
Free cash flow (dilution-adjusted): 98511000
Buyback yield (%): 9.32627989535539
Retained earnings: 219027000
Inventory turnover: 47.51143220948901
Receivables turnover: 19.065461524727727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.79587629227449
FCF margin (%): 4.612557960737234
Revenue growth (%): 1.598875031337665
Rule of 40 score: 6.211432992074899
Financial ratios for PZZA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 49.68
Shares outstanding: 32902014
Market cap (USD): 1634572055.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PZZA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 38.24
Shares outstanding: 32902014
Market cap (USD): 1258173015.3600001
Buyback yield (%): 0.16531907572384638
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PZZA — annual report dated 2024-12-31
Total revenue: 2059387000
Gross profit: 416626000
Operating income: 142688000
Net income: 84197000
Capital expenditures: 72484000
Operating cash flow: 106632000
Depreciation & amortization: 69407000
Net tangible assets: -504986000
Owner earnings: 81120000
Return on net tangible assets (%): -16.063811670026496
Capex to operating income (%): 50.79894595200718
Buffett classification: The Good
Stock price: 38.24
P/E ratio: 14.943204809672554
Shares outstanding: 32902014
Book value: -413313000
Market cap (USD): 1258173015.3600001
Debt to equity: -2.3496188118931656
Current ratio: 0.8296248061792397
Quick ratio: 0.7028273547198728
Effective tax rate (%): 26.22452377197133
Interest coverage ratio: 3.3512142420968574
COGS to revenue (%): 79.76941682160759
SG&A to revenue (%): 9.931644707866953
Free cash flow (dilution-adjusted): 24558000
Buyback yield (%): 0.16531907572384638
Retained earnings: 241717000
Inventory turnover: 46.609760249680804
Receivables turnover: 18.9248844411362
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.35361193082036
FCF margin (%): 1.192490775167562
Revenue growth (%): -3.5737947935888386
Rule of 40 score: -2.3813040184212766
Financial ratios for PZZA — quarterly report dated 2025-03-31
Total revenue: 518309000
Gross profit: 151813000
Operating income: 26100000
Net income: 9343000
Capital expenditures: 12231000
Operating cash flow: 31336000
Depreciation & amortization: 18343000
Net tangible assets: -507850000
Owner earnings: 15455000
Return on net tangible assets (%): -3.043221423648715
Capex to operating income (%): 46.86206896551724
Buffett classification: The Good
Stock price: 38.72
P/E ratio: 34.08878256662742
Shares outstanding: 32902014
Book value: -415939000
Market cap (USD): 1273965982.08
Debt to equity: -2.366344584181815
Current ratio: 0.8558354748514487
Quick ratio: 0.7243574561946137
Effective tax rate (%): 32.71640501224255
Interest coverage ratio: 2.5895426133544994
COGS to revenue (%): 70.7099432963734
SG&A to revenue (%): 20.715441946792357
Free cash flow (dilution-adjusted): 15436000
Buyback yield (%): 0
Retained earnings: 235794000
Inventory turnover: 9.853367388089797
Receivables turnover: 4.813329990156201
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.242598616035073
FCF margin (%): 2.978146240948932
Rule of 40 score: 2.978146240948932
Financial ratios for PZZA — quarterly report dated 2025-06-30
Total revenue: 529166000
Gross profit: 157450000
Operating income: 26965000
Net income: 9671000
Capital expenditures: 19440000
Operating cash flow: 35507000
Depreciation & amortization: 18819000
Net tangible assets: -508878000
Owner earnings: 9050000
Return on net tangible assets (%): -1.7784223330542879
Capex to operating income (%): 72.09345447802707
Buffett classification: The Good
Stock price: 46.66
P/E ratio: 80.74092633007257
Shares outstanding: 32902014
Book value: -415862000
Market cap (USD): 1535207973.2399998
Debt to equity: -2.3244658083691223
Current ratio: 0.815749467923381
Quick ratio: 0.6877299544617571
Effective tax rate (%): 30.454480080540776
Interest coverage ratio: 2.547713529856387
COGS to revenue (%): 70.24563180552038
SG&A to revenue (%): 21.102262806000386
Free cash flow (dilution-adjusted): 12243000
Buyback yield (%): 0
Retained earnings: 229868000
Inventory turnover: 9.919304050808561
Receivables turnover: 4.753728125336878
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.511302095793857
FCF margin (%): 2.3136407100985323
Revenue growth (%): 2.0946964069695877
Rule of 40 score: 4.40833711706812
Financial ratios for PZZA — quarterly report dated 2025-09-30
Total revenue: 508154000
Gross profit: 139024000
Operating income: 16402000
Net income: 4707000
Capital expenditures: 20452000
Operating cash flow: 39349000
Depreciation & amortization: 24914000
Net tangible assets: -506755000
Owner earnings: 9169000
Return on net tangible assets (%): -1.8093556057661002
Capex to operating income (%): 124.6921107182051
Buffett classification: The Gruesome
Stock price: 46.36
P/E ratio: 64.30324897938536
Shares outstanding: 32902014
Book value: -423451000
Market cap (USD): 1525337369.04
Debt to equity: -2.2438463954507135
Current ratio: 0.8713537025181048
Quick ratio: 0.7563033050326707
Effective tax rate (%): 28.156119498875682
Interest coverage ratio: 1.649270990447461
COGS to revenue (%): 72.64136462568433
SG&A to revenue (%): 19.228029298204873
Free cash flow (dilution-adjusted): 14258000
Buyback yield (%): 0
Retained earnings: 219041000
Inventory turnover: 10.322138642655407
Receivables turnover: 4.541630916630917
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8611399903709955
FCF margin (%): 2.805842323390153
Revenue growth (%): -3.9707766560965743
Rule of 40 score: -1.1649343327064212
Financial ratios for PZZA — annual report dated 2025-12-31
Total revenue: 2053808000
Gross profit: 425674000
Operating income: 84687000
Net income: 32117000
Capital expenditures: 73472000
Operating cash flow: 126000000
Depreciation & amortization: 92245000
Net tangible assets: -512326000
Owner earnings: 50890000
Return on net tangible assets (%): -9.933128515827812
Capex to operating income (%): 86.75711738519489
Buffett classification: The Gruesome
Stock price: 37.48
P/E ratio: 38.39609816358937
Shares outstanding: 32902014
Book value: -432686000
Market cap (USD): 1233167484.7199998
Debt to equity: -2.1640774141063033
Current ratio: 0.8159427611163231
Quick ratio: 0.6979459845837156
Effective tax rate (%): 33.61238579519616
Interest coverage ratio: 2.0772400598493954
COGS to revenue (%): 79.27391460155964
SG&A to revenue (%): 12.111258696041695
Free cash flow (dilution-adjusted): 36585000
Buyback yield (%): 0
Retained earnings: 210763000
Inventory turnover: 47.417695712954334
Receivables turnover: 18.232733212598983
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.495766828845214
FCF margin (%): 1.7813252261165602
Revenue growth (%): -0.27090585693704
Rule of 40 score: 1.5104193691795202
Financial ratios for PZZA — quarterly report dated 2025-12-31
Total revenue: 498179000
Gross profit: -22613000
Operating income: 15220000
Net income: 8630000
Capital expenditures: 21349000
Operating cash flow: 19808000
Depreciation & amortization: 30169000
Net tangible assets: -512326000
Owner earnings: 17450000
Return on net tangible assets (%): -3.406034439009537
Capex to operating income (%): 140.26938239159
Buffett classification: The Gruesome
Stock price: 37.48
P/E ratio: 38.118372993725075
Shares outstanding: 32902014
Book value: -432686000
Market cap (USD): 1233167484.7199998
Debt to equity: -2.1640774141063033
Current ratio: 0.8159427611163231
Quick ratio: 0.6979459845837156
Effective tax rate (%): 39.902506963788305
Interest coverage ratio: 1.497884066528885
COGS to revenue (%): 104.53913151698487
SG&A to revenue (%): 12.40919428558811
Free cash flow (dilution-adjusted): -5352000
Buyback yield (%): 0
Retained earnings: 210763000
Inventory turnover: 15.167520969245107
Receivables turnover: 4.422596853804907
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7849087951518436
FCF margin (%): -1.0743126466591324
Revenue growth (%): -1.9629875982477754
Rule of 40 score: -3.0373002449069078
Financial ratios for QTS.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 278.40909090909093
Shares outstanding: 166900000
Market cap (USD): 46466477272.72728
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QTS.DE — annual report dated 2022-12-31
Total revenue: 14410000000
Gross profit: 5028000000
Operating income: 1827000000
Net income: 1091000000
Capital expenditures: 674000000
Operating cash flow: 2260000000
Depreciation & amortization: 1130000000
Net tangible assets: -12976000000
Owner earnings: 1547000000
Return on net tangible assets (%): -11.92200986436498
Capex to operating income (%): 36.89107827038862
Buffett classification: The Good
Stock price: 246.22340425531914
P/E ratio: 37.66699007352224
Shares outstanding: 166900000
Book value: 5765000000
P/B ratio: 7.1283063608348245
Market cap (USD): 41094686170.21276
Debt to equity: 2.256895056374675
Current ratio: 0.8929723915381858
Quick ratio: 0.8929723915381858
Effective tax rate (%): 19.075568598679386
Interest coverage ratio: 4.391826923076923
COGS to revenue (%): 65.10756419153367
SG&A to revenue (%): 14.371963913948646
Free cash flow (dilution-adjusted): 1392000000
Buyback yield (%): 2.8422166193511846
Retained earnings: 3334000000
Receivables turnover: 4.868243243243243
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.246419353206134
FCF margin (%): 9.659958362248439
Rule of 40 score: 9.659958362248439
Financial ratios for QTS.DE — annual report dated 2023-12-31
Total revenue: 14984000000
Gross profit: 5239000000
Operating income: 2061000000
Net income: 1358000000
Capital expenditures: 649000000
Operating cash flow: 2149000000
Depreciation & amortization: 1125000000
Net tangible assets: -13294000000
Owner earnings: 1834000000
Return on net tangible assets (%): -13.795697307055816
Capex to operating income (%): 31.48956817079088
Buffett classification: The Good
Stock price: 257.16666666666663
P/E ratio: 31.60612420225822
Shares outstanding: 166900000
Book value: 6112000000
P/B ratio: 7.022434009598602
Market cap (USD): 42921116666.666664
Debt to equity: 2.2735602094240837
Current ratio: 0.8621167770759514
Quick ratio: 0.8621167770759514
Effective tax rate (%): 6.922549691569568
Interest coverage ratio: 3.0669642857142856
COGS to revenue (%): 65.03603844100374
SG&A to revenue (%): 13.701281366791243
Free cash flow (dilution-adjusted): 1283000000
Buyback yield (%): 2.3112166621946386
Retained earnings: 4692000000
Receivables turnover: 4.3902724875476125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.208023774145616
FCF margin (%): 8.562466631073145
Revenue growth (%): 3.9833448993754335
Rule of 40 score: 12.545811530448578
Financial ratios for QTS.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 257.16666666666663
Shares outstanding: 166900000
Market cap (USD): 42921116666.666664
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QTS.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Operating cash flow: 885000000
Buffett classification: The Gruesome
Stock price: 241.09375
Shares outstanding: 166900000
Market cap (USD): 40238546875
Quick ratio: 0
Free cash flow (dilution-adjusted): 885000000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QTS.DE — annual report dated 2024-12-31
Total revenue: 15405000000
Gross profit: 5375000000
Operating income: 2269000000
Net income: 1373000000
Capital expenditures: 577000000
Operating cash flow: 2716000000
Depreciation & amortization: 1114000000
Net tangible assets: -13142000000
Owner earnings: 1910000000
Return on net tangible assets (%): -14.533556536295844
Capex to operating income (%): 25.429704715733802
Buffett classification: The Good
Stock price: 241.09375
P/E ratio: 29.307026128914785
Shares outstanding: 166900000
Book value: 6067000000
P/B ratio: 6.632363091313664
Market cap (USD): 40238546875
Debt to equity: 2.3332783912971813
Current ratio: 0.8378611470461406
Quick ratio: 0.8378611470461406
Effective tax rate (%): 18.034751348112643
Interest coverage ratio: 3.3865671641791044
COGS to revenue (%): 65.10873093151575
SG&A to revenue (%): 12.930866601752678
Free cash flow (dilution-adjusted): 1908000000
Buyback yield (%): 3.3549919289922174
Retained earnings: 6065000000
Receivables turnover: 4.75462962962963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.377996188947948
FCF margin (%): 12.385589094449854
Revenue growth (%): 2.8096636412172984
Rule of 40 score: 15.195252735667152
Financial ratios for QTS.DE — quarterly report dated 2025-03-31
Total revenue: 3829000000
Gross profit: 1298000000
Operating income: 525000000
Net income: 249000000
Capital expenditures: 142000000
Operating cash flow: 568000000
Depreciation & amortization: 265000000
Net tangible assets: -13553000000
Owner earnings: 372000000
Return on net tangible assets (%): -2.7447797535600973
Capex to operating income (%): 27.047619047619047
Buffett classification: The Good
Stock price: 251.57608695652172
P/E ratio: 42.15667561550549
Shares outstanding: 166900000
Book value: 5985000000
P/B ratio: 7.015547019723221
Market cap (USD): 41988048913.04347
Debt to equity: 2.423893065998329
Current ratio: 0.8233737289316061
Quick ratio: 0.8233737289316061
Effective tax rate (%): 18.885448916408667
Interest coverage ratio: 3.1818181818181817
COGS to revenue (%): 66.10080961086446
SG&A to revenue (%): 13.267171585270304
Free cash flow (dilution-adjusted): 354000000
Buyback yield (%): 0.8931112773937617
Retained earnings: 6314000000
Receivables turnover: 1.1564482029598309
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.606364493868838
FCF margin (%): 9.245233742491513
Rule of 40 score: 9.245233742491513
Financial ratios for QTS.DE — quarterly report dated 2025-06-30
Total revenue: 4017000000
Gross profit: 1323000000
Operating income: 538000000
Net income: 266000000
Capital expenditures: 151000000
Operating cash flow: 443000000
Depreciation & amortization: 276000000
Net tangible assets: -14429000000
Owner earnings: 391000000
Return on net tangible assets (%): -2.7098205003811766
Capex to operating income (%): 28.066914498141266
Buffett classification: The Good
Stock price: 272.29411764705884
P/E ratio: 88.24444317532839
Shares outstanding: 166900000
Book value: 5786000000
P/B ratio: 7.854457005754254
Market cap (USD): 45445888235.29412
Debt to equity: 2.7134462495679226
Current ratio: 0.8379556259904913
Quick ratio: 0.8379556259904913
Effective tax rate (%): 17.3374613003096
Interest coverage ratio: 2.956043956043956
COGS to revenue (%): 67.06497386109037
SG&A to revenue (%): 12.671147622603934
Free cash flow (dilution-adjusted): 232000000
Buyback yield (%): 1.4456753416247712
Retained earnings: 6580000000
Receivables turnover: 1.1793893129770991
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5546058879392213
FCF margin (%): 5.775454319143639
Revenue growth (%): 4.909898145729956
Rule of 40 score: 10.685352464873596
Financial ratios for QTS.DE — quarterly report dated 2025-09-30
Total revenue: 4100000000
Gross profit: 1373000000
Operating income: 573000000
Net income: 332000000
Capital expenditures: 61000000
Operating cash flow: 908000000
Depreciation & amortization: 286000000
Net tangible assets: -14495000000
Owner earnings: 557000000
Return on net tangible assets (%): -3.842704380820973
Capex to operating income (%): 10.645724258289704
Buffett classification: The Great
Stock price: 272.29411764705884
P/E ratio: 53.65512188346413
Shares outstanding: 166900000
Book value: 6288000000
P/B ratio: 7.227399528513696
Market cap (USD): 45445888235.29412
Debt to equity: 2.415712468193384
Current ratio: 0.7027503526093088
Quick ratio: 0.7027503526093088
Effective tax rate (%): 18.627450980392158
Interest coverage ratio: 3.0317460317460316
COGS to revenue (%): 66.51219512195122
SG&A to revenue (%): 12.536585365853659
Free cash flow (dilution-adjusted): 717000000
Buyback yield (%): 0
Retained earnings: 6911000000
Receivables turnover: 1.2371756185878093
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8339680498540973
FCF margin (%): 17.48780487804878
Revenue growth (%): 2.0662185710729397
Rule of 40 score: 19.554023449121722
Financial ratios for QTS.DE — annual report dated 2025-12-31
Total revenue: 16310000000
Gross profit: 5430000000
Operating income: 2287000000
Net income: 1361000000
Capital expenditures: 528000000
Operating cash flow: 2654000000
Depreciation & amortization: 1144000000
Net tangible assets: -15075000000
Owner earnings: 1977000000
Return on net tangible assets (%): -13.114427860696518
Capex to operating income (%): 23.087013554875384
Buffett classification: The Great
Stock price: 227.3529411764706
P/E ratio: 27.8803863940874
Shares outstanding: 166900000
Book value: 6630000000
P/B ratio: 5.7232588057847575
Market cap (USD): 37945205882.35294
Debt to equity: 2.405580693815988
Current ratio: 0.7494603022307508
Quick ratio: 0.7494603022307508
Effective tax rate (%): 15.83909490886235
Interest coverage ratio: 3.1371742112482854
COGS to revenue (%): 66.70754138565297
SG&A to revenue (%): 12.256284488044145
Free cash flow (dilution-adjusted): 1804000000
Buyback yield (%): 3.2784115175365094
Retained earnings: 7425000000
Receivables turnover: 4.759264662970528
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.585022678885494
FCF margin (%): 11.060698957694665
Revenue growth (%): 5.874716001298279
Rule of 40 score: 16.935414958992943
Financial ratios for QTS.DE — quarterly report dated 2025-12-31
Total revenue: 4364000000
Gross profit: 1436000000
Operating income: 651000000
Net income: 514000000
Capital expenditures: 174000000
Operating cash flow: 735000000
Depreciation & amortization: 317000000
Net tangible assets: -15075000000
Owner earnings: 657000000
Return on net tangible assets (%): -4.358208955223881
Capex to operating income (%): 26.72811059907834
Buffett classification: The Good
Stock price: 227.3529411764706
P/E ratio: 27.8803863940874
Shares outstanding: 166900000
Book value: 6630000000
P/B ratio: 5.7232588057847575
Market cap (USD): 37945205882.35294
Debt to equity: 2.405580693815988
Current ratio: 0.7494603022307508
Quick ratio: 0.7494603022307508
Effective tax rate (%): 10.986964618249534
Interest coverage ratio: 3.373056994818653
COGS to revenue (%): 67.09440879926673
SG&A to revenue (%): 10.724106324472961
Free cash flow (dilution-adjusted): 501000000
Buyback yield (%): 0.5587003550785692
Retained earnings: 7425000000
Receivables turnover: 1.2734169827837758
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.013051930019439
FCF margin (%): 11.480293308890925
Revenue growth (%): 6.439024390243903
Rule of 40 score: 17.91931769913483
Financial ratios for ROC.L — annual report dated 2022-03-31
Total revenue: 0
Operating income: -47382.89473684211
Net income: 45019.73684210526
Capital expenditures: 0
Operating cash flow: 27148.684210526317
Net tangible assets: 1196400
Owner earnings: 45019.73684210526
Return on net tangible assets (%): 3.762933537454469
Buffett classification: The Gruesome
Stock price: 0.0011842105263157893
P/E ratio: 0.3347216922402455
Shares outstanding: 12725003
Book value: 1196400
P/B ratio: 0.012595354814443328
Market cap (USD): 15069.082499999999
Debt to equity: 0.09703012546411163
Current ratio: 4.348694765000018
Quick ratio: 4.348694765000018
Effective tax rate (%): 39.6070886433438
Interest coverage ratio: -5.342878338278933
Free cash flow (dilution-adjusted): 27148.684210526317
Buyback yield (%): 0
Retained earnings: -247678.94736842104
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.8768569586088923
Rule of 40 score: 0
Financial ratios for ROC.L — annual report dated 2023-03-31
Total revenue: 0
Operating income: -365939.5061728395
Net income: -366776.5432098765
Capital expenditures: 0
Operating cash flow: -575224.6913580246
Net tangible assets: 755771.6049382716
Owner earnings: -366776.5432098765
Return on net tangible assets (%): -48.53007718381181
Buffett classification: The Gruesome
Stock price: 0.0006172839506172839
Shares outstanding: 12725003
Book value: 755771.6049382716
P/B ratio: 0.010393272348593132
Market cap (USD): 7854.94012345679
Debt to equity: 0.033425082696941236
Current ratio: 7.4253219104293855
Quick ratio: 7.4253219104293855
Interest coverage ratio: -437.18436578171094
Free cash flow (dilution-adjusted): -575224.6913580246
Buyback yield (%): 0
Retained earnings: -599166.6666666666
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -47.33155128033163
Rule of 40 score: 0
Financial ratios for ROC.L — annual report dated 2024-03-31
Total revenue: 0
Operating income: -639588.6075949367
Net income: -640097.4683544304
Capital expenditures: 0
Operating cash flow: -539597.4683544304
Net tangible assets: 134807.59493670886
Owner earnings: -640097.4683544304
Return on net tangible assets (%): -474.82300137091784
Buffett classification: The Gruesome
Stock price: 0.0006329113924050633
Shares outstanding: 12725003
Book value: 134807.59493670886
P/B ratio: 0.05974292005483671
Market cap (USD): 8053.799367088608
Debt to equity: 0.14089466468853876
Current ratio: 1.7991863032339588
Quick ratio: 1.7991863032339588
Interest coverage ratio: -1256.902985074627
Free cash flow (dilution-adjusted): -539597.4683544304
Buyback yield (%): 0
Retained earnings: -1254432.911392405
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -438.9497002866823
Rule of 40 score: 0
Financial ratios for ROC.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -9144
Buffett classification: The Gruesome
Stock price: 0.0002666666666666667
Shares outstanding: 12725003
Book value: -9144
Market cap (USD): 3393.3341333333333
Debt to equity: -1.668853893263342
Current ratio: 0.9843569999393682
Quick ratio: 0.9843569999393682
Buyback yield (%): 0
Retained earnings: -1472477.3333333333
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ROC.L — annual report dated 2024-12-31
Total revenue: 0
Operating income: 299595
Net income: 299125
Capital expenditures: 0
Operating cash flow: 241960
Net tangible assets: 432247.5
Owner earnings: 299125
Return on net tangible assets (%): 69.20225102516498
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.00037499999999999995
P/E ratio: 0.015952782699540324
Shares outstanding: 12725003
Book value: 432247.5
P/B ratio: 0.011039684729234986
Market cap (USD): 4771.876125
Debt to equity: 0.028664133395797545
Current ratio: 4.268371414135744
Quick ratio: 4.268371414135744
Effective tax rate (%): 0
Interest coverage ratio: 637.436170212766
Free cash flow (dilution-adjusted): 241960
Buyback yield (%): 0
Retained earnings: -939627.5
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 68.61275002361752
Rule of 40 score: 0
Financial ratios for ROC.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 432247.5
Buffett classification: The Gruesome
Stock price: 0.00037499999999999995
Shares outstanding: 12725003
Book value: 432247.5
P/B ratio: 0.011039684729234986
Market cap (USD): 4771.876125
Debt to equity: 0.028664133395797545
Current ratio: 4.268371414135744
Quick ratio: 4.268371414135744
Buyback yield (%): 0
Retained earnings: -939627.5
Capitalized R&D asset: 0
Rule of 40 score: 0